All terms in MESHD
| Label | Id | Description |
|---|---|---|
| Ectodermal Dysplasia | D004476 | [A group of hereditary disorders involving tissues and structures derived from the embryonic ectoderm. They are characterized by the presence of abnormalities at birth and involvement of both the epidermis and skin appendages. They are generally nonprogressive and diffuse. Various forms exist, including anhidrotic and hidrotic dysplasias, FOCAL DERMAL HYPOPLASIA, and aplasia cutis congenita.] |
| Brown-Sequard Syndrome | D018437 | [A syndrome associated with injury to the lateral half of the spinal cord. The condition is characterized by the following clinical features (which are found below the level of the lesion): contralateral hemisensory anesthesia to pain and temperature, ipsilateral loss of propioception, and ipsilateral motor paralysis. Tactile sensation is generally spared. (From Adams et al., Principles of Neurology, 6th ed, p162).] |
| Paraplegia | D010264 | [Severe or complete loss of motor function in the lower extremities and lower portions of the trunk. This condition is most often associated with SPINAL CORD DISEASES, although BRAIN DISEASES; PERIPHERAL NERVOUS SYSTEM DISEASES; NEUROMUSCULAR DISEASES; and MUSCULAR DISEASES may also cause bilateral leg weakness.] |
| Akathisia, Drug-Induced | D017109 | [A condition associated with the use of certain medications and characterized by an internal sense of motor restlessness often described as an inability to resist the urge to move.] |
| Neurotoxicity Syndromes | D020258 | [Neurologic disorders caused by exposure to toxic substances through ingestion, injection, cutaneous application, or other method. This includes conditions caused by biologic, chemical, and pharmaceutical agents.] |
| Psychomotor Agitation | D011595 | [A feeling of restlessness associated with increased motor activity. This may occur as a manifestation of nervous system drug toxicity or other conditions.] |
| Hemolysis | D006461 | [The destruction of ERYTHROCYTES by many different causal agents such as antibodies, bacteria, chemicals, temperature, and changes in tonicity.] |
| Eye Hemorrhage | D005130 | [Intraocular hemorrhage from the vessels of various tissues of the eye.] |
| Eye Manifestations | D005132 | [Ocular disorders attendant upon non-ocular disease or injury.] |
| Eye Neoplasms | D005134 | [Tumors or cancer of the EYE.] |
| Hemoperitoneum | D006465 | [Accumulations of blood in the PERITONEAL CAVITY due to internal HEMORRHAGE.] |
| Thrombotic Microangiopathies | D057049 | [Diseases that result in THROMBOSIS in MICROVASCULATURE. The two most prominent diseases are PURPURA, THROMBOTIC THROMBOCYTOPENIC; and HEMOLYTIC-UREMIC SYNDROME. Multiple etiological factors include VASCULAR ENDOTHELIAL CELL damage due to SHIGA TOXIN; FACTOR H deficiency; and aberrant VON WILLEBRAND FACTOR formation.] |
| Lameness, Animal | D007794 | [A departure from the normal gait in animals.] |
| Hemoptysis | D006469 | [Expectoration or spitting of blood originating from any part of the RESPIRATORY TRACT, usually from hemorrhage in the lung parenchyma (PULMONARY ALVEOLI) and the BRONCHIAL ARTERIES.] |
| Hemophilia A | D006467 | [The classic hemophilia resulting from a deficiency of factor VIII. It is an inherited disorder of blood coagulation characterized by a permanent tendency to hemorrhage.] |
| Hemopneumothorax | D006468 | [Collection of air and blood in the pleural cavity.] |
| Hemothorax | D006491 | [Hemorrhage within the pleural cavity.] |
| Disease Progression | D018450 | [The worsening of a disease over time. This concept is most often used for chronic and incurable diseases where the stage of the disease is an important determinant of therapy and prognosis.] |
| Pyelocystitis | D053653 | [Inflammation of the KIDNEY PELVIS and the URINARY BLADDER.] |
| Pyelitis | D011702 | [Inflammation of the KIDNEY PELVIS and KIDNEY CALICES where urine is collected before discharge, but does not involve the renal parenchyma (the NEPHRONS) where urine is processed.] |